España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Edwards Lifesciences
EW
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$73.30
-1.41
-1.89%
At close: -
$73.30
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Edwards Lifesciences (EW) Forecast
News
Earnings
Edwards Lifesciences (EW) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Edwards Lifesciences (NYSE:EW) Stock
Edwards Lifesciences Stock (NYSE: EW)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, February 18, 2025
Peering Into Edwards Lifesciences's Recent Short Interest
Benzinga Insights
Friday, February 14, 2025
Insider Unloading: LESLIE HEISZ STONE Sells Options, Realizes $179K
Benzinga Insights
Thursday, February 13, 2025
Barclays Maintains Overweight on Edwards Life...
Benzinga Newsdesk
Canaccord Genuity Maintains Hold on Edwards L...
Benzinga Newsdesk
Wednesday, February 12, 2025
Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength
Vandana Singh
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
Piero Cingari
RBC Capital Reiterates Outperform on Edwards ...
Benzinga Newsdesk
Piper Sandler Maintains Neutral on Edwards Li...
Benzinga Newsdesk
Evercore ISI Group Maintains In-Line on Edwar...
Benzinga Newsdesk
Edwards Lifesciences shares are trading highe...
Benzinga Newsdesk
Morgan Stanley Maintains Equal-Weight on Edwa...
Benzinga Newsdesk
Edwards Lifesciences shares are trading highe...
Benzinga Newsdesk
Tuesday, February 11, 2025
Edwards Lifesciences shares are trading highe...
Benzinga Newsdesk
Edwards Lifesciences Sees Q1 Adj. EPS $0.58-$...
Benzinga Newsdesk
Edwards Lifesciences Q4 2024 Adj. EPS $0.59 B...
Benzinga Newsdesk
US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?
Piero Cingari
Earnings Scheduled For February 11, 2025
Benzinga Insights
Thursday, January 30, 2025
Edwards Lifesciences shares are trading highe...
Benzinga Newsdesk
Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion
Nabaparna Bhattacharya
11 Analysts Have This To Say About Edwards Lifesciences
Benzinga Insights
This Coca-Cola Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Avi Kapoor
Stifel Upgrades Edwards Lifesciences to Buy, ...
Benzinga Newsdesk
Friday, January 24, 2025
Smart Money Is Betting Big In Edwards Lifesciences Options
Benzinga Insights
Thursday, January 16, 2025
Wolfe Research Downgrades Edwards Lifescience...
Benzinga Newsdesk
Monday, December 16, 2024
Assessing Edwards Lifesciences: Insights From 20 Financial Analysts
Benzinga Insights
B of A Securities Upgrades Edwards Lifescienc...
Benzinga Newsdesk
Wednesday, December 11, 2024
Citigroup Maintains Buy on Edwards Lifescienc...
Benzinga Newsdesk
Thursday, December 05, 2024
Goldman Sachs Maintains Buy on Edwards Lifesc...
Benzinga Newsdesk
Truist Securities Reiterates Hold on Edwards ...
Benzinga Newsdesk
Stifel Maintains Hold on Edwards Lifesciences...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Edwards L...
Benzinga Newsdesk
Canaccord Genuity Maintains Hold on Edwards L...
Benzinga Newsdesk
Wednesday, December 04, 2024
Edwards Lifesciences Outlines Vision For Growth At Investor Conference
Vandana Singh
Edwards Lifesciences shares are trading highe...
Benzinga Newsdesk
Edwards Lifesciences Expects 2025 Sales Of $5...
Benzinga Newsdesk
Monday, December 02, 2024
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Vandana Singh
Wednesday, November 27, 2024
The Analyst Verdict: Edwards Lifesciences In The Eyes Of 17 Experts
Benzinga Insights
RBC Capital Maintains Outperform on Edwards L...
Benzinga Newsdesk
Monday, November 25, 2024
Edwards Lifesciences' SAPIEN 3 Ultra RESILIA ...
Benzinga Newsdesk
Wednesday, October 30, 2024
Why is Boston Scientific Stock Trading Lower On Wednesday?
Vandana Singh
Shares Of Boston Scientific See Volume; Compa...
Benzinga Newsdesk
TRISCEND II Trial Shows Edwards EVOQUE System...
Benzinga Newsdesk
Monday, October 28, 2024
Unpacking the Latest Options Trading Trends in Edwards Lifesciences
Benzinga Insights
Edwards Lifesciences Says EARLY TAVR Trial Sh...
Benzinga Newsdesk
Edwards Lifesciences Announces Results From T...
Benzinga Newsdesk
Friday, October 25, 2024
Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
Piero Cingari
Canaccord Genuity Maintains Hold on Edwards L...
Benzinga Newsdesk
JP Morgan Maintains Neutral on Edwards Lifesc...
Benzinga Newsdesk
Piper Sandler Maintains Neutral on Edwards Li...
Benzinga Newsdesk
Truist Securities Maintains Hold on Edwards L...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch